You are here

Overview of permitted indications and transition arrangements

16 November 2020

This online training resource provides an overview of permitted indications and the transition arrangements for medicines listed before 6 March 2018.

The module also provides links to resources that may assist sponsors in meeting the requirements for listed medicines.

This module takes approximately 10 minutes to complete.

Please note: We are in the process of updating this module. In the meantime, page 9 requires the following date corrections:

  • The transition period for permitted indications ends on 5 March 2021.
  • Changes to permitted indications can be done free of charge until 5 March 2021.
  • ARTG entries that have not transitioned to Permitted Indications will be cancelled on 6 March 2021.